21 бет - Ең жақсы онкологияның онкологтар - ЖОҒ-649 дәрігерлер

Контент Bookimed редакциялық саясатына сәйкес келеді және оның сапасын тексерген

Yesim Yildirim

Ahn Jin Seok

  • 4.5 Жақсы 22 пікірлер
  • Оңтүстік Корея, Сеул, Samsung Medical Center
  • Oncologist

Да Винчи роботының көмегімен жатырды алып тастау
$18,700 - $23,400
Қалқанша безін резекциялау
$6,850 - $9,150
Жатыр мойны қатерлі ісігінде сәулелі терапия
$3,830 - $10,100
Ақпарат

Kim Tae Joong

  • 4.5 Жақсы 22 пікірлер
  • Оңтүстік Корея, Сеул, Samsung Medical Center
  • Gynecologist. Oncogynecologist

Да Винчи роботының көмегімен жатырды алып тастау
$18,700 - $23,400
Қалқанша безін резекциялау
$6,850 - $9,150
Жатыр мойны қатерлі ісігінде сәулелі терапия
$3,830 - $10,100
Ақпарат

Choi Han Yong

  • 4.5 Жақсы 22 пікірлер
  • Оңтүстік Корея, Сеул, Samsung Medical Center
  • Oncosurgeon, Head of Samsung Department of Urology

Да Винчи роботының көмегімен жатырды алып тастау
$18,700 - $23,400
Қалқанша безін резекциялау
$6,850 - $9,150
Жатыр мойны қатерлі ісігінде сәулелі терапия
$3,830 - $10,100
Ақпарат

Agoritsa Stergiou-Tsaroucha

  • 4.6 Керемет 129 пікірлер
  • Германия, Гамбург, Asklepios Hospital Barmbek
  • A specialist in minimally invasive surgery who conducts hysterectomies and provides treatment for uterine myomas, ovarian diseases, and prolapse of pelvic organs.
  • Толығырақ оқу
Жатыр мойны қатерлі ісігінде сәулелі терапия
$9,272.22 - $13,908.33
Алқым безінің қатерлі ісігінде химиотерапия
$2,318.06 - $4,636.11
Ақпарат

Petra Reemts

  • 4.6 Керемет 129 пікірлер
  • Германия, Гамбург, Asklepios Hospital Barmbek
  • Chief Physician of the Obstetrics and Gynecology Department
Жатыр мойны қатерлі ісігінде сәулелі терапия
$9,272.22 - $13,908.33
Алқым безінің қатерлі ісігінде химиотерапия
$2,318.06 - $4,636.11
Ақпарат

Test Test Test

  • Жаңа
  • 75 жылдар тәжірибе
  • аккредитациялар:
  • Грекия, Салоникі, Veselibu Clinic
Мастэктомия
$4,000 - $5,000
Ақпарат

Nail Paksoy

  • 4.5 Жақсы 2 пікірлер
  • 14 жылдар тәжірибе
  • аккредитациялар:
  • Түркия, Істанбұл, Medipol Bahçelievler Hospital

  • PROFESSIONAL EXPERIENCE

    2011-2012
    Erzurum Koprukoyu State Hospital
    Department: General Medicine

    2012-2017
    Istanbul University Cerrahpaşa Medical Faculty
    Department: Internal Medicine

    06/2017-10/2017
    Istanbul Gaziosmanpasa Taksim Training and Research Hospital
    Department: Internal Medicine

    10/2017-11/2018
    Istanbul University Istanbul Medical Faculty
    Department: Allergy and Immunology Fellowship

    2018/2022
    Istanbul University Oncology Institute
    Department: Medical Oncology Fellowship

    2022-2023
    Tekirdag City Hospital
    Department: Medical Oncology Specialist

    2023-present
    Istanbul Medipol University Medipol Bahcelievler Private Hospital
    Department: Medical Oncology Assoc. Prof.

     

    EDUCATION

    2005-2011
    Medical Education
    Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

    2012-2017
    Internal Medicine
    Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

    2017-2018
    Allergy-Immunology Fellowship
    Istanbul University Istanbul Medical Faculty
    Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

    2018-2022
    Medical Oncology Fellowship
    Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

    2022
    ESMO Board Certification in Medical Oncology
    10th September 2022 in Paris, France.

    2023
    Medical Oncology Assoc. Prof.
    Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

     

    INTERNATIONAL CLINICAL TRIALS:

    1. Astefania - ROCHE

    • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
    • Role: Subinvestigator

    2. PFİZER

    • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
    • Role: Subinvestigator

    3. RECITE - AMGEN

    • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
    • Role: Subinvestigator

    4. NAVIGATE - BAYER

    • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
    • Role: Subinvestigator

    5. RUBY - Tesaro (PRA)

    • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
    • Role: Subinvestigator

    6. ENGOT-ov43/GOG-3036 - MSD

    • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
    • Role: Subinvestigator

    7. ASTRA ZENECA

    • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
    • Role: Subinvestigator

    8. ROSY-O - ASTRA ZENECA

    • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
    • Role: Subinvestigator
    •  

    INTERNATIONAL PUBLICATIONS

    I. Published journal articles indexed by SCI, SSCI, and AHCI

    Weekly Paclitaxel in Classic Kaposi Sarcoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
    • Journal: Medicine, 102(5)

    Carboplatin Desensitization in Ovarian Carcinoma

    • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
    • Journal: Medicine, 101(45), e31726

    High-Dose Chemotherapy for Ewing’s Sarcoma

    • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
    • Journal: Medicine, 101(49), e32213

    Multidrug Refractory TFE3(+) Renal Cell Carcinoma

    • Authors: Paksoy, Nail, et al.
    • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

    Crizotinib Efficacy in NSCLC with MET Alterations

    • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
    • Journal: Medicine, 101(50), e32368

    Clinicopathological Features in ALK Mutant NSCLC

    • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
    • Journal: Medicine, 101(34)

    PSMA-Based Tumor Burden in Prostate Cancer

    • Authors: HAS SIMSEK, Duygu, et al.
    • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

    Atezolizumab in Metastatic Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: European Urology Focus, 2021, 7.5: 1061-1066

    Pulmonary Sarcomatoid Carcinoma

    • Authors: FERHATOGLU, Ferhat, et al.
    • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

    Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

    • Authors: TURAL, Deniz, et al.
    • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

    Atezolizumab with Chemotherapy in Small Cell Lung Cancer

    • Authors: GÜRBÜZ, Mustafa, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

    FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

    • Authors: AY, Seval, et al.
    • Journal: Journal of Chemotherapy, 2022, 1-7

    Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

    • Authors: CIL, Ibrahim, et al.
    • Journal: Tumori Journal, 2022, 108.1: 19-25

    Real-Life Efficacy of Osimertinib in Advanced NSCLC

    • Authors: HIZAL, Mutlu, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

    ALK-Positive Cells Percentage and Alectinib Efficacy

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
    • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

    Real-World Data on Alectinib in ALK-Positive NSCLC

    • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
    • Journal: Future Oncology, 18(23), 2573-2582

    Prognostic Factors in Metastatic RCC with T790M Mutation

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

    • Authors: DEMIR, Semra, et al.
    • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

    Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

    • Authors: ÖZDEMIR, Seçil Kepil, et al.
    • Journal: Allergy, 2019, 74.6: 1187-1190

    Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

    • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
    • Journal: The Oncologist, oyad257

    Subsequent Treatments in Hormone-Positive Breast Cancer Progression

    • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
    • Journal: BMC cancer, 23(1), 192

    Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
    • Journal: Scientific Reports, 13(1), 8779

    Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

    • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
    • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

    Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

    • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
    • Journal: European Journal of Breast Health, 19(2), 128

    Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

    • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
    • Journal: Future Oncology, 19(10), 727-736

    Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

    • Authors: Dogan, I., Paksoy, N., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

    • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
    • Journal: Journal of Cancer Research and Therapeutics

    FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

    • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
    • Journal: Journal of Cancer Research and Therapeutics

    Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

    • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
    • Journal: [Not specified]

    Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

    • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
    • Journal: Medicine, 102(39), e35383

    Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

    • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
    • Journal: Medicine, 102(41), e35245

    Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

    Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

    Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

    Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

    Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

    Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

    Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

    Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

    Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

    Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

    Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

    Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

    Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

     

    Thesis:

    Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

    International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

    Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

    • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

    Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

    • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

    Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

    • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

    Efficacy of temozolomide in pretreated patients with metastatic sarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

    • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

    Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

    • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

    Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

    Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

    • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

    Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

    • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

    Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

    • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

     

     

  • Толығырақ оқу
Краниотомия
$10,000 - $15,000
Бауыр қатерлі ісігінде резекция
$15,000 - $17,000
Трахелэктомия
$2,500 - $3,500
Ақпарат

Seyda Gunduz

  • 4.4 Жақсы 17 пікірлер
  • 15 жылдар тәжірибе
  • Түркия, Істанбұл, Istinye University Liv Hospital Bahcesehir
Печень SIRT
$45,000 - $45,000
Туыстық емес донордан алынған жұлың кемігін аллогендік трансплантациялау
$110,000 - $110,000
Өкпе рагында химиялық терапия
$2,000 - $2,000
Ақпарат

Ezgi Sevic

  • 5 Керемет 1 пікірлер
  • 6 жылдар тәжірибе
  • Түркия, Ізмір, Assoc.Prof.Dr.Cemal Kara / Medical Park İzmir Hospital
  • NUTRITION AND DIET SPECIALIST 

    Ezgi Sevic graduated from Hacettepe University, Department of Nutrition and Dietetic as Honor Student. During her education, she conducted studies on “'The Effect of Hedonic Eating Behavior on Obesity', 'Total Parenteral Nutrition in Children' and 'The Relationship Between Insulin Resistance and Obesity'.” During her education, she took part in the field in studies on determining the nutritional status of the society. She worked as intern dietitian in Hospitals of Hacettepe University (Oncology Hospital, Adults Hospital, İhsan Doğramacı Child Hospital), Dışkapı Yıldırım Beyazıt Training and Research Hospital and many Community Health Centres. 
    She worked in Izmir Private Ekol Hospital. She successfully completed the 'Bariatric Nutrition Course' and the 'Innovations in Obesity Course'. She has participated in many training and seminar programs in her field. 

    Interests: Post- Metabolic and Bariatric Surgery Nutrition, the Nutrition in Chronicle Diseases, Nutrition in Individuals with Diabetes, Nutrition in Cancer, Nutrition in Congenital Metabolic Diseases, Food Intolerances, Body Weight Control, Child and Adolescent Nutrition, Nutrition in Old Age, Nutrition in Pregnancy and Lactation.

    Dietit. Ezgi Sevic knows advanced English. 

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Serap Kaya

  • 4.4 Жақсы 32 пікірлер
  • 25 жылдар тәжірибе
  • Түркия, Істанбұл, Emsey Hospital
  • Dr. Serap Kaya is a medical oncologist with a specialization in Medical Oncology from Kocaeli University Faculty of Medicine. She has worked at several leading hospitals, including Oltu State Hospital, Kocaeli State Hospital, Marmara University Pendik Training and Research Hospital, and Medistate Kavacik Hospital. Dr. Kaya has made important contributions to cancer care at these institutions.

    She is known for her evidence-based approach and focus on patient outcomes. Dr. Kaya has managed many complex oncology cases. She holds accreditation from top Turkish medical faculties. Dr. Kaya is committed to improving oncology practice through ongoing professional development and clinical excellence.

  • Толығырақ оқу
Асқазан рагына операция
$14,500 - $20,000
Асқазан рагында сәулелік терапия
$9,000 - $15,500
Іш қуысына жіті енгізілетін химиотерапия HIPEC
$28,000 - $47,000
Ақпарат

Jumana Baryhe

  • Жаңа
  • 11 жылдар тәжірибе
  • Түркия, Істанбұл, Aesthetical Clinic
  • Dr. Jumana Baryhe is a specialist in advanced aesthetic and hair restoration procedures. She performs Botox injections, non-surgical nose correction, FUE and DHI hair transplants, beard and eyebrow transplants, brow lifts, lip implants, and laser vaginal rejuvenation. Dr. Baryhe is known for her skill in minimally invasive techniques. Her patients report high satisfaction with their results.

    Dr. Baryhe is dedicated to excellence in her field. She has completed hundreds of successful procedures. Her reputation is built on technical expertise and personalized care. She uses the latest methods and follows international standards in cosmetic medicine.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Doga Seckin

  • 4.5 Жақсы 234 пікірлер
  • 18 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Ulus
  • Медициналық қызығушылықтар 

    Бедеулік және жатырішілік инсеминация (IUI) 

    ЭКҰ емдеу 

    Гинекологиялық лапароскопиялық операциялар 

    Гистероскопиялық операциялар 

    Жүктілік және табиғи–кесарлы босану 

    Эндометриоз және аденомиоз 

    Лапароскопиялық эндометриоз операциясы 

    Жатыр миомасы және миома операциясы 

    Фаллопиялық түтік аурулары және операциялары 

    Жұмыртқалық кисталары және байланысты лапароскопиялық операциялар 

    Несеп ұстамау операциясы 

    Гинекологиялық эстетикалық операция 

    Жатыр және жамбас органдарының түсуін емдеу операциясы 

    Жатыр мойнының преонкологиялық зақымдары және емдеулері

    Білім 

    Анкара университетінің медицина факультеті (1999 - 2006) 

    Анкарадағы Доктор Зекей Тахир Бурак Әйелдер денсаулығы мен зерттеу ауруханасы, мамандық (2007 - 2012) 

    Стамбул Кануні Сұлтан Сүлейман оқыту және зерттеу ауруханасы асистент профессор (2015 - 2017) 

    IRCAD Страсбург, Франциядағы Еуропалық кеңейтілген гинекологиялық лапароскопиялық хирургия кеңесі (2013) 

    Стамбул Кануні Сұлтан Сүлейман оқыту және зерттеу ауруханасы доцент (2017 - 2020) 

    IRCAD Страсбург, Франциядағы Еуропалық эндометриоз хирургия кеңесі (2019) 

    Тәжірибе 

    Стамбул Кануні Сұлтан Сүлейман оқыту және зерттеу ауруханасы (2014 - 2020) 

    Стамбул Шишлі Колан Интернэшнл ауруханасы (2020 - 2021) 

    Лив Ауруханасы Улуз (2021 -) 

    Мүшеліктер 

    Түрік репродуктивті медицина қауымдастығы 

    Түрік-неміс гинекологиялық қауымдастығы 

    Түрік гинекология және акушерлік қауымдастығы 

    Еуропалық гинекологиялық эндоскопия қауымдастығы 

    Минималды инвазивті гинекология қауымдастығы 

    Минималды инвазивті урогинекология қауымдастығы 

    Еуропалық урогинекология қауымдастығы

    Маңызды бұрынғы жағдайлар

    Децидуализацияланған жасөспірімдік кистоздық аденомиоманы лапароскопиялық басқару, жүктікті ұқсастыратын жұмсақ тұстан. 

    Сол жақтағы бүйрек аномалиясы және жартылай қынаптың бөгелуі синдромы күрделенген эндометриоз және дермоидтық ісік бір жұмыртқалықта бірегей эндометриома ретінде ұсынылған. 

    Пиометрамен күрделі гемивагин және ипсилатералды бүйрек аномалиясы синдромы; лапароскопиялық геми гистерэктомияға арналған кеңестер мен әдістер. 

    Вагиналды гистерэктомиядан кейін манжеті түсу қаупін алдын-ала алу үшін модификацияланған перитонсыз жатырлық білек байламын ілу; 4 қысқыш әдісі. 

    Роберттің жатырын лапароскопиялық соқыр эндометриалдық қуысты резекциялау. 

    Тыртықты жүктілікті лапароскопиялық эксцизиялау және истмоцеле жөндеу. 

    Манчестер процедурасы ретроперитональды туннел арқылы лапароскопиялық сакрохистеропексиямен бірге

  • Толығырақ оқу
Ақпарат

Hakan Teoman Yanar

  • 4.5 Жақсы 234 пікірлер
  • 29 жылдар тәжірибе
  • Түркия, Істанбұл, Liv Hospital Ulus
  • Medical Interests and Activities 

    Gastrointestinal diseases 

    Oncologic laparoscopic surgery 

    Anorectal area diseases 

    Urgent surgical cases (acute cholecystitis, divertikülit, ileus, pankreatit, appendicitis) 

    Colon and rectum cancer 

    Treatment of oncologic surgical cases with further laparoscopic and robotic surgery. 

    Laparoscopic hernia surgery 

    Esophagus and stomach cancer 

    Selim anorectal diseases (hemorrhoidal disease, anal fissure), perianal fistula, pilonoidal sinus (hairless- non-surgical treatment)

    Education and Experience 

    İstanbul University Medical Faculty 1988 

    University of Colorado Health Science Center – Intern Surgeon 

    Isparta, Dedeçam Şehit Ramazan Karaca Health Center (1995-1996) 

    İstanbul Surgery Hospital – American Hospital (2000-2001) 

    Chief assistant Istanbul Medical Faculty, Department of General Surgery (2001-2008) 

    World Congress on Peritonel Surface Malignancies (HIPEC course) Berlin, Germany (2012) 

    USC Keck School of Medicine, Los Angeles, CA, USA (2006-2007) 

    Assoc. Prof. M.D. , İstanbul Medical Faculty General Surgery (2008-2014) 

    Da Vinci Robotic Intensive Course at IRCAD, Strasbourg, France (2011) 

    Stony Brook Medicine Cadaver Training Event in Colon and Rectal Surgery, New York, USA (2016) (Instructor) 

    Fellow of the European Board of Surgery- Emergency Surgery (FEBS EmSurg) Honorary Diploma (2017) 

    Prof. M.D. , İstanbul Medical Faculty General Surgery (2014 -2017) 

    İstanbul University Medical Faculty – General Surgery Master of Science 1996 

    University of Southern California Medical Center, Department of General Surgery, Los Angeles, USA – February 2006 – February 2007

    Liv Hospital

    Memberships 

    Turkish Society of Surgery 

    National Endoscopic Laparoscopic Surgery Association 

    Turkish Colon and Rectum Surgery Association 

    National Trauma and Emergency Surgery Association 

    Hepato-Pancreato-Bilier Surgery Association 

    Istanbul Surgical Association 

    Flebology Association 

    ESTES (European Society of Trauma and Emergency Surgery) 

    International Society of Surgery (ISS)

  • Толығырақ оқу
Ақпарат

Djuran Bogdan

  • 4.9 Керемет 21 пікірлер
  • 29 жылдар тәжірибе
  • Украина, Киев, Dievo Surgery Center
  • Surgical treatment: all types of operations in urology.

    General management of the medical service. Polyclinic reception of patients. Participation in councils. "Second opinion" in difficult cases, expert assessment of clinical situations. Organization and holding of master classes, workshops, webinars.

     

    Techniques that the doctor possesses:

    TUIP of the prostate and TOIP of the formations of the urinary bladder.

    Laser enucleation of the prostate, laser dissection of bladder tumors.

    Laser vaporization of the prostate gland.

    Laser incision of urethral strictures

    Contact laser uretero- , pyelo- and cystolithotripsy

    Percutaneous (mini) nephrolithotripsy

    Intrarenal retrograde and antegrade surgery (RIRS and AIRS) Operation Boari.

    Plastic surgery of the urethra in case of injury or stricture

    Transvesical access prostatectomy

    Cystostomy - open and trocar

    Nephrostomy

    Radical nephrectomy (including laparoscopic)

    Suturing of the rupture of the kidney

    Pyelolithotomy

    Ureterolithotomy

    Pelvic-ureteral plastic surgery (laparoscopic)

    Removal of kidney cysts (Cystectomy) (laparoscopic)

    Ureterocystoneostomy

    Ureterocutaneostomy

    Operations for intra-abdominal and retroperitoneal ruptures of the urinary bladder

    Orchectomy

    Epididymectomy

    Bergmann and Winckelmann operations

    Revision of organs of the portico due to injuries and inflammatory diseases

    Operation of Ivanisevich and Marmar for varicocele, circumcision, percutaneous nephrostomy, nephrolithotripsy

    Puncture of kidney cysts

  • Толығырақ оқу
Ұрық безінің протездеуі
$700 - $1,500
Бүйректі алып тастау
$1,400 - $3,000
Қуықты алып тастау
$1,500 - $2,000
Ақпарат

Jürgen Kiwit

  • 4.7 Керемет 17 пікірлер
  • 34 жылдар тәжірибе
  • аккредитациялар:
  • Германия, Берлін, Meoclinic Hospital
  • Prof. Jürgen Kiwit is a German neurosurgeon with over 25 years of experience. He is the Head of the Neurosurgery Department at Meoclinic Berlin and specializes in the treatment of spinal cord and brain tumors pathologies, blood circulation disorders, and paraplegia. He has trained in the UK and USA and is a member of various professional societies. His expertise includes glioma therapy, complicated brain aneurysms surgeries, anti-pain therapy, brain injuries differentiated therapy, and nervous system dysfunctions.

  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Elnur Sahibov

  • 4.4 Жақсы 32 пікірлер
  • 9 жылдар тәжірибе
  • Түркия, Істанбұл, Emsey Hospital
  • Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.

    Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.

  • Толығырақ оқу
Асқазан рагына операция
$14,500 - $20,000
Асқазан рагында сәулелік терапия
$9,000 - $15,500
Іш қуысына жіті енгізілетін химиотерапия HIPEC
$28,000 - $47,000
Ақпарат

Muslum Tarkan

  • Жаңа
  • 28 жылдар тәжірибе
  • Түркия, Ескішехір, Klinik Mavi
  • Dr. Muslum Tarkan is a specialist in bariatric surgery with over 15 years of experience. He is proficient in numerous operations including but not limited to lumpectomy, mastectomy, thyroid resection, removal of colon and liver cancer, and various types of gastric surgeries.
  • Толығырақ оқу
Бауырды резекциялау
$6,000 - $8,000
Лампэктомия
$1,500 - $2,000
Ақпарат

Fuad Nurili

  • Жаңа
  • 17 жылдар тәжірибе
  • Түркия, Істанбұл, Menfis Health Novimaj
  • Dr. Fuad Nurili is a board-certified radiologist specializing in obesity treatment and interventional oncology. He is a co-founder of a medical institution, known for his extensive research, contributions to medical literature, and commitment to patient care.
  • Толығырақ оқу
Дәрігерге бару
Бағасы сұрау бойынша
Ақпарат

Plamen Staikov

  • 4 Жақсы 14 пікірлер
  • 31 жылдар тәжірибе
  • аккредитациялар:
  • Германия, Майндағы Франкфурт, Sachsenhausen Hospital
  • Dr. Plamen Straikov is a highly experienced surgeon specializing in bariatric and metabolic surgery. He is Medical Director at Sachsenhausen Hospital and has extensive experience in revision surgery before bariatric/metabolic surgery. He has held honorary professorship roles at V. N. Karazin Kharkiv National University and Odessa National Medical University, and is a member of several medical organizations.

  • Толығырақ оқу
Ақпарат

Orhan Tanriverdi

  • 4.5 Жақсы 234 пікірлер
  • 32 жылдар тәжірибе
  • аккредитациялар:
  • Түркия, Істанбұл, Liv Hospital Ulus
  • Dr. Kemal Raşa is a highly experienced General Surgeon specializing in Modern Thyroidology & Laparoscopic Surgery with 23 years of experience. He is affiliated with several medical associations and has published several papers in his field.

  • Толығырақ оқу
Ақпарат